COMMUNIQUÉS West-GlobeNewswire
-
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
17/07/2026 -
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026 -
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
17/07/2026 -
4DMT Announces New Employment Inducement Grants
17/07/2026 -
Immuneering Corporation Announces Grants of Inducement Awards
17/07/2026 -
AlkaLean Releases Updated 2026 Details About Its Natural GLP-1 Supplement Ingredient List with Baking Soda Recipe, Pricing, Refund Policy & Customer Service Support
17/07/2026 -
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026 -
Vaxart Announces Results of Annual Meeting of Stockholders
17/07/2026 -
Report on Carbios’ liquidity contract
17/07/2026 -
CARBIOS : Bilan semestriel du contrat de liquidité
17/07/2026 -
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
17/07/2026 -
Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
17/07/2026 -
Skyline LASIK Introduces WaveLight® Plus LASIK, Advancing Precision in Vision Correction
17/07/2026 -
Damora Announces Redomestication from Delaware to Cayman Islands
17/07/2026 -
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
17/07/2026 -
Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
17/07/2026 -
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
17/07/2026 -
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026 -
Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction
17/07/2026
Pages